What Researchers Did
Researchers conducted a bibliographic review to understand how hyperbaric oxygen therapy (HBOT) works in the context of radiation therapy for cancer patients.
What They Found
The review found Grade B and C evidence that HBOT at pressures exceeding 2 absolute atmospheres (ata) reduced late-onset radiation injuries to the head and neck, bone, prostate, and bladder. It also appeared to prevent osteoradionecrosis after exodontia in irradiated areas. Furthermore, HBOT at 2 ata increased the effectiveness of radiation in head and neck tumours and showed promising results for local control of high-grade gliomas.
What This Means for Canadian Patients
Canadian patients experiencing severe late-onset radiation toxicity may benefit from hyperbaric oxygen therapy as a treatment option for their injuries. Additionally, HBOT could potentially enhance the effectiveness of radiation therapy for certain cancers, offering improved outcomes.
Canadian Relevance
This review does not have a specific Canadian connection or focus.
Study Limitations
The findings are primarily based on Grade B and C evidence, often derived from small series or individual cases, indicating a need for higher quality research.